Literature DB >> 26807618

Oncologic Outcomes of Invasive Squamous Cell Carcinoma of the Scalp Requiring Resection of Cranial Bone.

Andrea Ziegler1, Ronald Walker2, Mark Varvares3.   

Abstract

Objectives To identify the recurrence rates and survival outcomes of patients with invasive squamous cell carcinoma of the scalp. Methods This study was a retrospective chart review of eight patients that had squamous cell carcinoma of the scalp with either periosteal or skull invasion on clinical and/or radiographic evaluation. Results The disease-free survival was 62.5% (5/8 patients) with a local control rate of 75% (6/8 patients) for the entire group. The two patients with full-thickness craniectomy had a local control rate of 100% (2/2 patients); the patients with outer cortex removal had a local control rate of 66.7% (4/6 patients). The disease-free survival of the full-thickness group was 50% (1/2 patients ), and the disease-free survival of the outer cortex removal patients was 66.7% (4/6 patients). Conclusion Despite the invasive nature of this disease, a high degree of local control can be achieved in this high-risk group with multiple comorbidities using outer cortex drilldown, and, in properly selected patients, full-thickness calvarial resection. We conclude that for patients without evidence of medullary involvement that outer table drilldown offers a well-tolerated approach with reasonable oncologic control. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2016        PMID: 26807618     DOI: 10.1055/s-0035-1567859

Source DB:  PubMed          Journal:  J Neurol Surg A Cent Eur Neurosurg        ISSN: 2193-6315            Impact factor:   1.268


  1 in total

1.  Management of a recurrence of a squamous cell carcinoma of the scalp with extension to the brain: A case report and literature review.

Authors:  Mohamed Chabaane; Khalil Ayadi; Mouna Rkhami; Cyrine Drissi; Sarra Houimli; Kamel Bahri; Ihsen Zammel; Mohamed Badri
Journal:  Surg Neurol Int       Date:  2020-10-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.